Synovus Financial Corp Becton Dickinson & CO Transaction History

Synovus Financial Corp

  • $8.55 Billion
  • Q3 2025

A detailed history of Synovus Financial Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Synovus Financial Corp holds 10,301 shares of BDX stock, worth $1.97 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,301
Previous 9,517 8.24%
Holding current value
$1.97 Million
Previous $1.64 Million 17.63%
% of portfolio
0.02%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$172.41 - $199.66 $135,169 - $156,533
784 Added 8.24%
10,301 $1.93 Million
Q2 2025

Aug 14, 2025
SELL
$165.15 - $226.42 $130,798 - $179,324
-792 Reduced 7.68%
9,517 $1.64 Million
Q1 2025

May 14, 2025
BUY
$222.79 - $249.08 $118,301 - $132,261
531 Added 5.43%
10,309 $2.36 Million
Q4 2024

Feb 13, 2025
BUY
$220.02 - $243.75 $167,435 - $185,493
761 Added 8.44%
9,778 $2.22 Million
Q3 2024

Nov 14, 2024
BUY
$221.47 - $242.41 $178,947 - $195,867
808 Added 9.84%
9,017 $2.17 Million
Q2 2024

Aug 13, 2024
SELL
$225.07 - $246.17 $18,230 - $19,939
-81 Reduced 0.98%
8,209 $1.92 Million
Q1 2024

May 14, 2024
BUY
$233.45 - $247.73 $255,394 - $271,016
1,094 Added 15.2%
8,290 $2.05 Million
Q3 2023

Nov 13, 2023
BUY
$254.9 - $283.59 $757,562 - $842,829
2,972 Added 70.36%
7,196 $1.86 Million
Q2 2023

Aug 08, 2023
BUY
$238.39 - $265.32 $150,900 - $167,947
633 Added 17.63%
4,224 $1.12 Million
Q1 2023

May 11, 2023
SELL
$229.71 - $259.35 $91,884 - $103,740
-400 Reduced 10.02%
3,591 $888,000
Q4 2022

Feb 06, 2023
BUY
$218.29 - $256.91 $76,183 - $89,661
349 Added 9.58%
3,991 $1.02 Million
Q3 2022

Oct 27, 2022
BUY
$51.03 - $264.23 $1,990 - $10,304
39 Added 1.08%
3,642 $808,000
Q2 2022

Aug 10, 2022
BUY
$234.74 - $275.42 $111,501 - $130,824
475 Added 15.19%
3,603 $890,000
Q1 2022

May 12, 2022
SELL
$243.64 - $270.48 $52,382 - $58,153
-215 Reduced 6.43%
3,128 $834,000
Q4 2021

Feb 14, 2022
SELL
$230.08 - $250.94 $28,760 - $31,367
-125 Reduced 3.6%
3,343 $842,000
Q3 2021

Nov 08, 2021
BUY
$232.72 - $256.47 $7,214 - $7,950
31 Added 0.9%
3,468 $853,000
Q2 2021

Aug 11, 2021
BUY
$232.65 - $254.58 $23,497 - $25,712
101 Added 3.03%
3,437 $836,000
Q1 2021

May 11, 2021
SELL
$232.09 - $256.88 $6,498 - $7,192
-28 Reduced 0.83%
3,336 $811,000
Q4 2020

Feb 11, 2021
SELL
$221.92 - $245.94 $27,296 - $30,250
-123 Reduced 3.53%
3,364 $846,000
Q3 2020

Nov 09, 2020
SELL
$215.77 - $276.76 $1,941 - $2,490
-9 Reduced 0.26%
3,487 $811,000
Q2 2020

Aug 10, 2020
SELL
$219.9 - $263.41 $185,155 - $221,791
-842 Reduced 19.41%
3,496 $837,000
Q1 2020

Apr 24, 2020
BUY
$195.69 - $279.01 $224,065 - $319,466
1,145 Added 35.86%
4,338 $997,000
Q4 2019

Feb 06, 2020
SELL
$236.45 - $266.82 $9,458 - $10,672
-40 Reduced 1.24%
3,193 $867,000
Q3 2019

Nov 01, 2019
BUY
$230.58 - $256.08 $1,152 - $1,280
5 Added 0.15%
3,233 $822,000
Q2 2019

Aug 08, 2019
SELL
$217.4 - $246.08 $61,741 - $69,886
-284 Reduced 8.09%
3,228 $813,000
Q1 2019

May 09, 2019
SELL
$206.05 - $248.17 $136,611 - $164,536
-663 Reduced 15.88%
3,512 $876,000
Q4 2018

Feb 07, 2019
BUY
$204.73 - $257.93 $120,381 - $151,662
588 Added 16.39%
4,175 $943,000
Q3 2018

Nov 01, 2018
BUY
$233.07 - $256.0 $466 - $512
2 Added 0.06%
3,587 $938,000
Q2 2018

Aug 01, 2018
BUY
$208.1 - $233.85 $32,463 - $36,480
156 Added 4.55%
3,585 $859,000
Q1 2018

May 07, 2018
SELL
$205.46 - $240.27 $81,156 - $94,906
-395 Reduced 10.33%
3,429 $743,000
Q4 2017

Feb 09, 2018
SELL
$189.0 - $222.64 $93,933 - $110,652
-497 Reduced 11.5%
3,824 $818,000
Q3 2017

Nov 13, 2017
BUY
$186.89 - $198.9 $807,551 - $859,446
4,321
4,321 $847,000

Others Institutions Holding BDX

# of Institutions
1,719
Shares Held
257M
Call Options Held
1.01M
Put Options Held
544K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $54.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email